The automotive engine management system (EMS) market is experiencing a significant surge, with a projected growth rate of 5% during the 2022-2028 period. This growth is fueled by several factors, including:
Access sample report (including graphs, charts, and figures): https://univdatos.com/get-a-free-sample-form-php/?product_id=33256
- Rising Vehicle Complexity: Modern cars are packed with advanced features, demanding a sophisticated engine control system to optimize performance and efficiency.
- Stringent Emission Regulations: Governments worldwide are implementing stricter emission standards, necessitating advanced EMS technology to meet these regulations.
- Focus on Fuel Economy: Consumers are increasingly demanding fuel-efficient vehicles. Engine management systems play a crucial role in optimizing fuel consumption.
Market Dynamics and Key Players:
The report highlights Robert Bosch GmbH, ZF Friedrichshafen AG, Autoliv Inc., Continental AG, BorgWarner Inc., DENSO CORPORATION, HELLA GmbH & Co. KGaA., Panasonic Holdings Corporation, Hitachi, Ltd, and Infineon Technologies AG as prominent players in the engine management system market. These companies are actively involved in mergers and acquisitions, forming partnerships to develop cutting-edge technologies and cater to the evolving customer demands.
Engine and Vehicle Type Segmentation:
- Engine Type: While diesel engines held a dominant share in 2020 due to their inherent efficiency, the landscape is shifting. Growing environmental concerns are pushing manufacturers towards cleaner gasoline engines. Additionally, stricter emission regulations necessitate advanced engine management systems for both diesel and gasoline engines to achieve compliance.
- Vehicle Type: Commercial vehicles held a significant market share in 2020 due to the rising demand from businesses. However, the passenger car segment is expected to witness considerable growth due to increasing disposable income and the growing preference for personal vehicles.
Regional Market Analysis:
The report emphasizes the Asia-Pacific (APAC) region as a potential growth driver. Stringent emission regulations like China 6a/6b and India's BS VI norms are mandating the adoption of advanced engine management systems. Additionally, the burgeoning luxury car market in the region further propels the demand for sophisticated EMS technology.
Looking Ahead: Trends and Forecasts
Several trends are shaping the future of the engine management system market:
- Electrification: The growing adoption of electric vehicles (EVs) will present both challenges and opportunities. While the core functionalities of engine management systems might differ for EVs, there will be a need for managing electric motors and battery systems efficiently.
- Connected Cars: The integration of car connectivity features with engine management systems will pave the way for real-time monitoring, remote diagnostics, and proactive maintenance.
- Artificial Intelligence (AI): AI-powered engine management systems are anticipated to further optimize engine performance, fuel efficiency, and emission control.
Click here to view the Report Description & TOC https://univdatos.com/report/automotive-engine-management-system-market/
Market Forecast:
The market is expected to maintain a steady growth trajectory due to the aforementioned factors. The increasing demand for fuel-efficient and environment-friendly vehicles coupled with stringent emission regulations will continue to drive the market forward. Additionally, continuous technological advancements and the integration of features like connectivity and AI are poised to revolutionize the engine management system landscape.
Contact Us:
UnivDatos Market Insights
Email - sales@univdatos.com, contact@univdatos.com
Contact Number - 0120 455 9411
Website - https://univdatos.com/
Non-Small Cell Lung Cancer Market is Expected to Increase With a CAGR of 10.7% for the Study Period of 2017-2030: DelveInsight (Albany, US) DelveInsight has introduced a new Market Insights, Epidemiology, and Market Forecast Report on "Non-Small Cell Lung Cancer Market Insights, Epidemiology, and Market Forecast-2030" to its portfolio.Key Highlights from report are:As per the DelveInsight analysis, the total incident cases of NSCLC in the 7MM were observed to be 484,726 cases in the year 2017.
These cases are expected to grow with a significant CAGR in the study period 2017–2030.There are different types of treatment available for NSCLC; however, mainly 10 types of standard treatment are used, which include Surgery, Radiation therapy, Chemotherapy, Targeted therapy, Immunotherapy, Laser therapy, Photodynamic therapy (PDT), Cryosurgery, Electrocautery, and Watchful waiting.The market size of NSCLC in the 7MM is expected to increase during study period.
According to the estimates, the highest contribution in the market size of NSCLC is from the United States followed by Japan, Germany, and the UK.One of the most exciting developments in lung cancer medicine is the introduction of targeted treatments.Request for free sample pages to know more on Non-Small Cell Lung Cancer Market Forecast NSCLC is the most common type of lung cancer accounted for approximately 85% of all lung cancers.
The disease epidemiology included in the report provides historical as well as forecasted Non-Small Cell Lung Cancer epidemiology, which is segmented as Total Incident cases of NSCLC patients, Total Incident cases of NSCLC patients by Histology, Total Diagnosed cases of NSCLC patients by Stages, Total NSCLC cases of patients by Genetic mutation/Biomarkers, and Total Treated Cases of NSCLC patients by Line of Therapies scenario of NSCLC in the 7MM.The total NSCLC incident cases in the 7MM were observed to be 484,726 cases in 2017.Click here to know more on Non-Small Cell Lung Cancer pipelineNSCLC report encloses the detailed analysis of Non-Small Cell Lung Cancer marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs.
The therapies that are approved for the NSCLC treatment are Rozlytrek (Entrectinib), Imfinzi (Durvalumab), Opdivo (Nivolumab), Tecentriq (Atezolizumab), Keytruda (Pembrolizumab), Tafinlar (Dabrafenib) in combination with Mekinist (Trametinib), Tagrisso (osimertinib), Lorbrena/Lorviqua (Lorlatinib), Vizimpro (Dacomitinib), Alunbrig (Brigatinib), Alecensa (Alectinib), Vitrakvi (Larotrectinib), Portrazza (Necitumumab) along with many more.Drugs covered in the report are:-There are several key players robustly involved in developing potential products such asNazartinib (EGF816)Capmatinib (INC280)Tepmetko (tepotinib)MerestinibJNJ-61186372 (JNJ-6372)Vemurafenib Plus CobimetinibX-396 (Ensartinib)Tedopi (OSE2101)Selpercatinib (LY3527723/ LOXO-292)SAR408701Braftovi (encorafinib) + Mektovi (binimetinib)PADCEV (enfortumab vedotin/ASG-22ME)Pralsetinib (BLU-667)TAK-788: Canakinumab (ACZ885)Avelumab (Bavencio)Veliparib (ABT-888): Sitravatinib (MGCD516)TesevatinibRomiplostim: CabozantinibSym015AMG 510INCMGA00012 (MGA012)Libtayo (Cemiplimab)BavituximabM7824 (Bintrafusp alfa)And many others Key Players covered in the report are:-Novartis PharmaceuticalsMerck KGaAEli Lilly and CompanyJanssen Research & DevelopmentHoffmann-La RocheXcoveryBeyondSpring PharmaceuticalsOSE ImmunotherapeuticsSanofiPfizerAstellas PharmaSeattle GeneticsBlueprint Medicines CorporationTakedaAbbVieKadmon CorporationAmgenSymphogenRegeneron PharmaceuticalsPeregrine PharmaceuticalsAvid BioservicesGlaxoSmithKlineAnd many othersThe report includes provides in depth analysis historical and forecasted Market Share (%) Distribution of NSCLC, Market Share (%) Distribution of NSCLC by Mutations/Biomarkers, Total Market Size of PD-L1 NSCLC, Total Market Size of BRAF NSCLC, Total Market Size of c-Met, Total Market Size of EGFR, Total Market Size of ALK as well.The reasons for buying this report:The report proffers an overview of pathophysiology, various diagnostic approaches and NSCLC treatment algorithm, including detailed chapters for marketed products and emerging therapies.Historical and forecasted Non-Small Cell Lung Cancer epidemiology in 7MM covering the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2017-2030.Detailed historical and forecasted NSCLC market covering the United States, EU5 and Japan from 2017-2030.
Pipeline analysis across different stages of development (Phase III and Phase II), different emerging trends and comparative analysis of pipeline products with comprehensive clinical profiles, key cross-competition, launch date along with product development activities.
Latest Research Report on “Sports Medicine Products Market” Added by Analytical Research Cognizance which covers Market Overview, Future Economic Impact, Competition by Manufacturers, Supply (Production), & Consumption Analysis
This report studies the global market size of Sports Medicine Products Market in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Sports Medicine Products in these regions.
This report also studies the global Sports Medicine Products market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
Get Sample for Sports Medicine Products Market Report @ http://www.arcognizance.com/enquiry-sample/131077
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Market size by End User
The Spirulina Market is expected to grow at a CAGR of 10.3% from 2020-2030, according to a new research report by Next Move Strategy ConsultingSpirulina is a blue green algae with high nutrient content, usually consumed by human & animals.
It is also used as a complementary diet ingredient in aquaculture & poultry feeds owing to the presence of high protein & vitamin content.According to the report, growth in health consciousness among people and the rising demand for dietary supplements are major factors driving the spirulina market growth.
Additionally, high penetration of spirulina in industries such as cosmetics and pharmaceutical owing to the advantageous properties such as anti-aging, anti-wrinkles and othersare bringing changes in market tends.However, low stability & poor sustainability of spirulina derived colours is expected to restrict the market growth.Moreover, growth in research & development activities followed by untapped market opportunities in developing economies are anticipated to provide numerous opportunities to the market players in the coming few years.On the basis of type, spirulina market share is segmented into Arthrospira Platensis and Arthrospira Maxima.
Arthrospira Maxima dominates the global Spirulina market and will be the dominant throughout the forecasted period.On the basis of application, the Spirulina market is categorised into Nutraceuticals, Food & Beverages, Cosmetics, Animal Feed, and Others.Food & Beverages segment is likely to develop significantly over the period of time owing to fast growing food & beverage industry.On the basis of drug formulation, the spirulina market is bifurcated into Powder, Tablet & Capsule, Liquid, and Granule & Gelling Agent.
Powder segment is expected to account for the major market share & dominate the market growth over the forecast period.North America dominates the spirulina market in terms of market size over the forecast period, owing to rising health consciousness among people.
Hansen Holding A/S, Algenol Biofuels Inc., Dongtai City Spirulina Bio-engineering Co., Ltd., Prolgae, Parry Neutraceuticals, Sensient Technologies Corporation, DDW Inc., Algatec and Naturex S.A.Browse key industry insights from the report, “Spirulina Market Size By Type (ArthrospiraPlatensis and Arthrospira Maxima) By Application (Nutraceuticals, Food & Beverages, Cosmetics, Animal Feed, and Others), By Drug Formulation (Powder, Tablet & Capsule, Liquid, and Granule & Gelling Agent)Regional Outlook (U.S., Canada, Germany, UK, France, Spain, Italy, Russia, China, India, Japan, Australia, Indonesia, Malaysia, South Korea, Brazil, Mexico, South Africa, Saudi Arabia, UAE, Kuwait), Growth Potential, Price Trends, Competitive Market Share & Forecast, 2020–2030” in detail along with the table of contents:Key Insights from the Spirulina Market Report:Asia Pacific is the fastest growing region in Spirulina market owing to the rising demand of spirulina from various industries such as cosmetics, food , healthcare and others and government initiatives to promote local spirulina production.The Food & Beverages segment dominates the market in terms of application and is expected to grow at a significant CAGR to maintain the lead till 2030.Some of the major players in the market are DIC Corporation, Cyanotech Corporation, Chr.
Esticast Research & Consulting adds a new research report titled, ‘Global Automotive Engine Management System Market’ to its huge database of research reports.
The domain experts who have planned the report have thoroughly studied the global Automotive Engine Management System market and have catered reliable and accurate data.They recognize the needs of the industry and the clients, which makes it simple for them to focus on the aspects, which the clients have been looking for.
The research report comprises of an analysis of an evaluation of the existing and upcoming trends that companies can invest in.
Furthermore, it also includes an assessment of the financial outlooks of the players and explains the scenario of the competition.Research MethodologyThe research methodology of the market is based on both primary as well as secondary research data sources.
It commits different factors affecting Automotive Engine Management System industry such as market environment, different policies of the government, historical data and market trends, technological advancements, forthcoming innovations, market risk factors, market restraints, and obstacles in the industry.Competitive Landscape:The key players' profile in the report includesContinental AG Infineon Technologies AGDenso Corp. BorgWarner IncRobert Bosch GmbHHitachi LtdSanken Electric Co.Ltd Sensata TechnologiesNGK Spark Plug Co.LtdDelphi Automotive PLCHella KGaA Hueck & Co.The key player’s major focus is on product innovations and technologies that improve shelf life and efficiency.
The long-term success and growth opportunities can be examined by bull’s eye through tracking the on-going process improvements linked with financial aspects and to be decisive to invest in the most favorable strategies.
